Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Dundee Corp DNDPF


Primary Symbol: T.DC.A Alternate Symbol(s):  T.DC.P.B | T.DC.P.D | DNDEF | DDEJF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate Corporation. Corporate and Other Portfolio Holdings segment invests in public and private equity and debt securities in diversified industry segments. Goodman & Company, Investment Counsel Inc. includes the activities of Dundee Global Investment Management Inc. Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. United Hydrocarbon International Corp., an 84%-owned private subsidiary engaged in oil and gas exploration through the holding of a royalty interest in the Republic of Chad.


TSX:DC.A - Post by User

Comment by TheCount11on Mar 12, 2024 8:57am
60 Views
Post# 35928085

RE:RE:RE:Lot of potential here

RE:RE:RE:Lot of potential hereI get that investors are pissed off about taking on debt to buy back preferred stock.  It pisses me off too. 

Investors are missing the option value of a TauRx IPO. 

HMTM is oral with a benign safety profile that requires minimal testing and treatment monitoring designed for early intervention to modify the underlying disease process and slow progression of Alzheimer’s.

In other words this medication would likely be prescribed by GPs who have become comfortable with Cholinesterase Inhibitors (Aricept & Exelon) over last couple of decades.
 
 A $15B USD TauRx IPO would get Dundee over $600M CAD, a $30B USD IPO would get $1.2B CAD and a $45B IPO would get $1.8B CAD.

Dundee currently has a market value of $80M.  

The placebo arm of the study was not actually a placebo resulting in missed end point.  Is this holding down Dundee?




<< Previous
Bullboard Posts
Next >>